NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
A. Dimitrios Colevas, Anthony J. Cmelak, David G. Pfister, Sharon A. Spencer, Douglas Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Jimmy J. Caudell, Greg Andrew Durm, Carole Fakhry, Thomas J. Galloway, J.L. Geiger, Maura L. Gillison, Christine M. Glastonbury, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Aditya Juloori, Michael Kase, Debra S. Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, Katharine A. Price, James W. Rocco, Cristina P. Rodriguez, David A. Schwartz, Jatin P. Shah, David J. Sher, Maie A. St. John, He Wang, Gregory S. Weinstein, Francis P. Worden, Justine Y. Bruce, Sue S. Yom, Weining Zhen, Sarah Montgomery, Susan Darlow
Abstract
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.